| Literature DB >> 36221388 |
Kohei Kamegai1,2, Shuhei Yokoyama1, Shunichi Takakura1, Yoshihiro Takayama1, Soichi Shiiki1, Hirofumi Koyama3, Masashi Narita1,4.
Abstract
RATIONALE: Diagnosing multifactorial, multidimensional symptoms unexplained by presumptive diagnosis is often challenging for infectious disease specialists. PATIENT CONCERNS: We report a rare case of a 30-year-old Japanese bisexual man with a history of virally suppressed human immunodeficiency virus and syphilis infections who developed chest pain and an erosive lesion under the lower midline jaw. DIAGNOSIS: Imaging examinations revealed erosive lesions on the sternum and left the ninth rib. Biopsy and polymerase chain reaction testing of sternal tissue specimens were noncontributory. However, due to elevated rapid plasma regain levels, a diagnosis of syphilitic osteomyelitis and gumma of the jaw was made.Entities:
Mesh:
Substances:
Year: 2022 PMID: 36221388 PMCID: PMC9542556 DOI: 10.1097/MD.0000000000030733
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1.Osteolytic lesion in the sternum on plain computed tomography scan (white arrow).
Figure 2.Clinical course of submandibular gumma before antibiotic treatment (left) and after 3 months of treatment (right).
Figure 3.Plain magnetic resonance imaging (short T1-inversion recovery mode) of the right hand conducted 1 month before starting antibiotic treatment. The radius, ulna, and second metacarpal bone show high intensity.
The characteristics of patients with syphilitic bone involvement.
| Parameter | Total (N = 46) | (%) | HIV positive (N = 24) | (%) | Non-HIV (N = 22) | (%) |
|---|---|---|---|---|---|---|
| Male sex | 40/46 | (87) | 24/24 | (100) | 16/22 | (72.7) |
| Age, median (range) | 41 (20–71) | 40 (20–66) | 47 (20-71) | |||
| Clinical findings | ||||||
| Bone pain | 46/46 | (100) | 24/24 | (100) | 22/22 | (100) |
| Early phase signs | ||||||
| Recent history of genital ulcer | 3/46 | (6.5) | 1/17 | (5.9) | 2/12 | (16.7) |
| Rash | 26/46 | (56.5) | 12/21 | (57.1) | 14/19 | (73.7) |
| Lymphadenopathy | 11/46 | (23.9) | 5/19 | (26.3) | 6/17 | (35.3) |
| None of the above | 10/46 | (21.7) | 7/24 | (29.2) | 3/22 | (13.6) |
| Nontreponemal test (VDRL or RPR) | 46/46 | (100) | 46/46 | (100) | 46/46 | (100) |
| Sites of the affected bones | ||||||
| Skull | 25/46 | (54.3) | 14/24 | (58.3) | 11/22 | (50.0) |
| Long bone of the limbs or fingers | 22/46 | (47.8) | 15/24 | (62.5) | 7/22 | (31.8) |
| Vertebra | 7/46 | (15.2) | 3/24 | (12.5) | 4/22 | (18.2) |
| Rib | 4/46 | (8.7) | 3/24 | (12.5) | 1/22 | (4.5) |
| Clavicle | 2/46 | (4.3) | 1/24 | (4.2) | 1/22 | (4.5) |
| Sternum | 2/46 | (4.3) | 1/24 | (4.2) | 1/22 | (4.5) |
| Pelvis | 1/46 | (2.1) | 1/24 | (4.2) | 0/22 | (0) |
| Histologic findings of bone biopsy | ||||||
| | 11/24 | (45.8) | 2/10 | (20) | 9/14 | (64.3) |
| Average weeks from the onset to diagnosis (range) | 7.0 (1–36) | 7.3 (2–36) | 6.7 (1–16) | |||
HIV = human immunodeficiency virus, RPR = rapid plasma regain, VDRL = Venereal Disease Research Laboratory.
Treatment for syphilis with bone involvement.
| Antibiotics regimen (including combination therapy) | No. of patients | (%) |
|---|---|---|
| Intramuscular benzathine penicillin | 26/43 | (60) |
| Once a week, for 9 wk | 1/26 | |
| Once a week, for 4 wk | 1/26 | |
| Once a week, for 3 wk | 14/26 | |
| Once a week, for 2 wk | 5/26 | |
| Once a week, for 1 wk | 4/26 | |
| Once a week, within 3 wk | 23/26 | |
| Unknown duration | 1/26 | |
| Combination with aqueous penicillin | 8/26 | |
| Intravenous aqueous penicillin | 19/43 | (44) |
| 6 wk | 2/19 | |
| 3 wk | 3/19 | |
| 2 wk | 10/19 | |
| Unknown duration | 4/19 | |
| Oral doxycycline | 3/43 | (7) |
| 16 wk | 1/43 | |
| 6 wk | 1/43 | |
| 4 wk | 1/43 | |
| Intravenous ceftriaxone | 2/43 | (5) |
| 5 wk | 1/2 | |
| 3 wk | 1/2 | |
| Oral azithromycin | 2/43 | (5) |
| 10 wk | 1/2 | |
| 2 wk | 1/2 | |
| Intravenous nafcillin | 1/43 | (2) |
| Unknown duration | 1/1 |